"Bid speculation also boosted shares in Shire, the country's third-biggest drugmaker, which closed up 3% at 955.5p. There is persistent talk that AstraZeneca could launch a bid, with UBS analysts saying that Astra could afford to pay £14.25p a share."
http://www.guardian.co.uk/business/2008/apr/19/marketforces.banking
Saturday, April 19, 2008
SHP
